BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Felypressin

A synthetic analog of LYPRESSIN with a PHENYLALANINE substitution at residue 2. Felypressin is a vasoconstrictor with reduced antidiuretic activity.

110+ PubMed studies analyzed · 24 RCTs · Evidence Score: 54.2

Research Domains

Felypressin has been studied across 11 research domains including ❤️ Cardiovascular, 💊 Pain, 😴 Sleep, 🫘 Kidney, 🧠 Focus & Attention. The primary research focus is ❤️ Cardiovascular with 32% of studies addressing this area.

Loading evidence profile...

This evidence profile for Felypressin is generated deterministically from 110 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.